Artificial intelligence and robotics are revolutionizing drug discovery by automating laboratory processes and enabling rapid, data-driven breakthroughs. This hybrid approach is cutting costs, ...

In the second part of his Pharma Commerce video interview, Kevin Dondarski, Deloitte’s life sciences R&D strategy leader, ...

President Donald Trump is right that Americans pay too high a price for many pharmaceuticals. In a May 12 speech and signing ...

Organoids, organs-on-a-chip, and machine learning technologies have improved dramatically in recent years, but have they come ...

Sometimes it is said that drug companies need to charge a high price to recoup the cost of development ... Second, the rate of return in the pharmaceutical industry has to be higher than in ...

Using estimated failure rates at each stage ... So 50% of the total cost of drug development is attributed to what the authors describe as 'time costs'. Although second nature to economists ...

One way to keep prescription costs down is to increase clinical success rates. Inevitably a drug is priced not only to recoup its own development costs but also to pay for the failed drug programs ...

Let’s dig into the relative performance of Corcept (NASDAQ:CORT) and its peers as we unravel the now-completed Q1 branded ...

Testing drug compounds on ... explain why there is a 90% failure rate during clinical development. The low rate of success is one of the contributors to the high cost and the slow R&D process ...

Absci entered its new drug into Phase I trials in half the time and for many millions of dollars less than it would have cost without AI.

Donald Trump has announced a new executive order aimed at significantly reducing prescription drug prices in the U.S., ...

A new study finds that CivicaScript, a not-for-profit drug manufacturer in the US, can reliably supply essential generic ...